Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Swanton to Join Allergan Executive Leadership Team Following Departure of Rob Stewart, Executive Vice President and Chief Operating Officer DUBLIN, Dec. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) a leading global bio... Biopharmaceuticals, Personnel Allergan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2017 Category: Pharmaceuticals Source Type: news

Robert Stewart to Join Amneal Pharmaceuticals as President
BRIDGEWATER, N.J., Dec. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that Robert Stewart, 50, will join Amneal as President, effective January 25, 2018. Mr. S... Biopharmaceuticals, Personnel, Mergers & Acquisitions Impax Laboratories, Amneal Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2017 Category: Pharmaceuticals Source Type: news

Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Company announces strategic relationship with ZOLL Medical MINNETONKA, Minn., Dec. 18, 2017 -- (Healthcare Sales & Marketing Network) -- Respicardia, Inc., a private medical technology company, announced today that the company has closed a $58.5 millio... Devices, Venture Capital Respicardia, remedē System, ZOLL Medical, sleep apnea, neurostimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2017 Category: Pharmaceuticals Source Type: news

Elekta Collaborates with Palabra to offer the Industry's Only Voice-enabled EHR
Palabra dictation system will be available as an addition to Elekta's MOSAIQ Oncology Information System to reduce time needed for a multitude of clinical tasks STOCKHOLM, Dec. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) to... Devices, Oncology, Product Launch Elekta, Palabra, MOSAIQ (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2017 Category: Pharmaceuticals Source Type: news

Rigel Announces Departure of Chief Financial Officer
Launches Search for Chief Financial Officer with Commercial-Stage Expertise SOUTH SAN FRANCISCO, Calif., Dec. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the resignation of Ryan Mayna... Biopharmaceuticals, Personnel Rigel Pharmaceuticals, fostamatinib, tyrosine kinase, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2017 Category: Pharmaceuticals Source Type: news

Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Intranasal abuse-deterrent claim to be added to ARYMO ER prescribing information label WAYNE, Pa., Dec. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (Nasdaq: EGLT) (Egalet), a fully integrated specialty pharmaceutical compan... Biopharmaceuticals, FDA Egalet Corp, ARYMO ER, morphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2017 Category: Pharmaceuticals Source Type: news

Silk Therapeutics Appoints Dr. Rebecca Lacouture to Company President
Lacouture Assumes Expanded Role to Further the Company's Efforts in Fabric Development MEDFORD, Mass., Dec. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Silk Therapeutics, Inc., a silk biomaterials company, today announced its board of direct... Devices, Personnel Silk Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 14, 2017 Category: Pharmaceuticals Source Type: news

Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
SAN DIEGO, Dec. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Companion Medical, a leader in the development of advanced technology to improve diabetes care, announced today that it has begun commercial sales of the InPen® system in the United... Devices, Drug Delivery, Endocrinology, Product Launch Companion Medical, InPen, Insulin Pen (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 14, 2017 Category: Pharmaceuticals Source Type: news

Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Bactericidal antibiotic cream indicated for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older Demonstrated activity against most isolates both in vitro and in clini... Biopharmaceuticals, Dermatology, FDA Medimetriks Pharmaceuticals, Xepi, ozenoxacin, Impetigo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 14, 2017 Category: Pharmaceuticals Source Type: news

Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus(R) Patents
HERTFORDSHIRE, England and PITTSBURGH, Dec. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has instituted inter partes review (IPR) proceedings on... Biopharmaceuticals, Generics, Litigation Mylan, Sanofi, Lantus, insulin glargine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 14, 2017 Category: Pharmaceuticals Source Type: news

Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
NEWARK, Calif., Dec. 14, 2017 -- (Healthcare Sales & Marketing Network) -- Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today announced the appointment of Sarah Noonberg, M.D., Ph.D., Chief Medical Officer of Prothena Corporation plc, to the Protagonist ... Biopharmaceuticals, Gastroenterology, Personnel Protagonist Therapeutics, inflammatory bowel disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 14, 2017 Category: Pharmaceuticals Source Type: news

Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance
NORTHBROOK, Ill., Dec. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Astellas today announced Anthony Fiordaliso, M.B.A., C.P.A., has been promoted to vice president, Americas Finance, reporting to Stephen Knowles, senior vice president, Finance a... Biopharmaceuticals, Personnel Astellas (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2017 Category: Pharmaceuticals Source Type: news

Kangen Pharmaceuticals Co., Ltd. Announces Acquisition Of KC Specialty Therapeutics
TOKYO and KANSAS CITY, Kan., Dec. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Kangen Pharmaceuticals ("Kangen") and KC Specialty Therapeutics ("KCST") today announced that Kangen has reached an agreement with KCST and agreed ... Biopharmaceuticals, Mergers & Acquisitions Kangen Pharmaceuticals, KC Specialty Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2017 Category: Pharmaceuticals Source Type: news

Leica Biosystems and KUB Technologies, Inc. Announce New Distribution Agreement
CINCINNATI, Dec. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Leica Biosystems and KUB Technologies, Inc. are pleased to announce a new global distribution agreement for Kubtec's specimen imaging systems. This agreement includes Kubtec's XPERT&re... Devices, Radiology, Oncology, Distribution Leica Biosystems, KUB Technologies, breast specimen imaging, 3D Tomosynthesis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2017 Category: Pharmaceuticals Source Type: news

Millar, Inc. Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences
HOUSTON, Dec. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Millar, Inc., a leader in medical device manufacturing, today announces the sale of the life sciences telemetry product division to Kaha Sciences, located in Auckland, New Zealand. The tr... Devices, Monitoring, Acquisitions Millar, Kaha Sciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2017 Category: Pharmaceuticals Source Type: news

Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
SAN FRANCISCO, Dec. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatenin... Biopharmaceuticals, Personnel Audentes Therapeutics, gene therapy, X-Linked Myotubular Myopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2017 Category: Pharmaceuticals Source Type: news

FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
SILVER SPRING, Md., Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA),... Biopharmaceuticals, FDA GlaxoSmithKline, Nucala, mepolizumab, eosinophilic granulomatosis, Churg-Strauss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

CompactCath Receives CE Mark For Its Flagship Discreet Intermittent Urinary Catheter
Approval clears the way for distribution of CompactCath in 28 countries across Europe, bringing new generation of intermittent catheters to EU patients PALO ALTO, Calif., Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) -- CompactCath (www.compa... Devices, Urology, Regulatory CompactCath, Intermittent Urinary Catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
DUBLIN, Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment is the first and only non-surgical fat reduction technology to be FDA-cleared for improved appearance of lax ... Devices, Dermatology, FDA Allergan, CoolSculpting (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
VANCOUVER, Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that it... Biopharmaceuticals, Cardiology, Licensing Cardiome Pharma, ZAO Firma Euroservice, Correvio, Aggrastat (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Phase 3 ALCYONE data showed DARZALEX in combination with bortezomib, melphalan and prednisone meaningfully improved progression-free survival and response rates Data featured as late-breaker at ASH 2017 (Abstract #LBA-4) and published in the New England... Biopharmaceuticals, Oncology Janssen Biotech, DARZALEX, daratumumab, multiple myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
PARIS, December 12, 2017 -- (Healthcare Sales & Marketing Network) -- Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, today announced the appointment of Dr. Patricia Zilliox as CEO. Dr. Zilliox, ... Biopharmaceuticals, Ophthalmology, Personnel Eyevensys, EyeCET, gene therapy, electro-transfection injection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
STAINES-UPON-THAMES, United Kingdom, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Ocera Therapeutics, a clinica... Biopharmaceuticals, Mergers & Acquisitions Mallinckrodt, Ocera Therapeutics, hepatic encephalopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
PARAMUS, N.J., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Polaryx Therapeutics, Inc. is a biotech company developing patient-friendly oral small molecule therapeutics for Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) and other form... Biopharmaceuticals, Neurology, FDA Polaryx Therapeutics, Neuronal Ceroid Lipofuscinoses (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

OncoTartis Closes $6M Financing Round
Proceeds to Support Clinical Trials of Promising Cancer Treatment BUFFALO, N.Y., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- OncoTartis, Inc., a biotechnology company developing a novel category of anti-cancer drugs, has concluded a $6 m... Biopharmaceuticals, Oncology, Venture Capital OncoTartis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
TARRYTOWN, N.Y., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics Licen... Biopharmaceuticals, Ophthalmology, FDA Regeneron Pharmaceuticals, EYLEA, aflibercept, macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Galcanezumab is the first of three investigational, non-opioid treatments in Lilly's pain portfolio INDIANAPOLIS, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug A... Biopharmaceuticals, FDA Eli Lilly, Galcanezumab, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
INDIANAPOLIS, Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that Kimberly Blackwell, M.D., one of the nation's leading breast cancer researchers, will join Lilly Oncology as vice president of ... Biopharmaceuticals, Oncology, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China
Ardelyx to Receive Up to $125 Million in Upfront Payment and Subsequent Milestones FREMONT, Calif., Dec. 11, 2017 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (NASDAQ: ARDX) today announced that the company has entered into a license agre... Biopharmaceuticals, Gastroenterology, Licensing Ardelyx, Fosun Pharma, tenapanor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2017 Category: Pharmaceuticals Source Type: news

Stryker announces definitive agreement to acquire Entellus
Kalamazoo, Michigan – December 7, 2017 -- (Healthcare Sales & Marketing Network) -- Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of a... Devices, Mergers & Acquisitions Stryker, Entellus Medical, Multi-Sinus Dilation System, Absorbable Nasal Implant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2017 Category: Pharmaceuticals Source Type: news

Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules
BRIDGEWATER, N.J., Dec. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration ("FDA") approva... Biopharmaceuticals, Generics, FDA Impax Laboratories, Coreg CR, carvedilol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2017 Category: Pharmaceuticals Source Type: news

VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
The VitalPatch wearable biosensor will include 5-day wear duration in alignment with nation's average hospital stay SAN JOSE, Calif., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- VitalConnect, Inc., a leader in wearable biosensor technolog... Devices, Monitoring, FDA VitalConnect, VitalPatch (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

John Walsh, M.D. Joins EMD Serono as Vice President of Neurology and Immunology, US Medical Affairs
ROCKLAND, Mass., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced the appointment of John Walsh, M.D. as Vice President, Neurology ... Biopharmaceuticals, Personnel EMD Serono, Merck KGaA, Rebif, interferon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
EVANSTON, Ill., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the appointment of Andy Kidd, B.M.... Biopharmaceuticals, Neurology, Personnel Aptinyx, neuropathic pain, PTSD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Medicare patients suffering from chronic peripheral nerve pain will have greater access to treatment starting January 1, 2018 VALENCIA, Calif., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Bioness, Inc., the leading provider of cutting edg... Devices, Neurology, Reimbursement Bioness, StimRouter, Neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
Oncologist-Executive Brings Extensive Medical and Informatics Experience to Rapidly Growing Precision Medicine Company SAN FRANCISCO, Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Syapse, a market leader in precision medicine solutions, ann... Oncology, Personnel Syapse, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
WAYNE, Pa., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Camber Spine announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SPIRA™-C Open Matrix Cervical Interbody device, an inno... Devices, Orthopaedic, Neurosurgery, FDA Camber Spine Technologies, SPIRA-C, Open Matrix, Interbody fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences
Acquisition Marks Further Success for the Epidarex Portfolio BETHESDA, Md., Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Epidarex Capital ("Epidarex"), an early-stage, transatlantic life science venture fund, today announced that... Devices, Cardiology, Mergers & Acquisitions Epidarex Capital, Harpoon Medical, Edwards Lifesciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
SAN DIEGO, Dec. 7, 2017 -- (Healthcare Sales & Marketing Network) -- Metacrine, Inc., an innovative biotechnology company focused on drug development, today announced it has closed a $22M Series B financing led by new investor New Enterprise Associates (N... Biopharmaceuticals, Venture Capital, Personnel Metacrine, FXR agonist (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 7, 2017 Category: Pharmaceuticals Source Type: news

ImpediMed Launches FDA-Approved SOZO(TM)
Diagnostic Device Aids in Clinical Assessment of Lymphedema CARLSBAD, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- ImpediMed Limited (ASX: IPD), a global provider of medical technology that non-invasively measures, monitors and man... Devices, Product Launch ImpediMed, SOZO, lymphedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Viriom Announces New Director Appointment
SAN DIEGO, Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Viriom Inc. is pleased to announce the appointment of Augustine Lawlor as Director of Viriom. Mr. Lawlor brings to Viriom his extensive operating experience in strategic business develo... Biopharmaceuticals, Personnel Viriom (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
GAITHERSBURG, Md., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Office of Orphan Product De... Biopharmaceuticals, Oncology, FDA Sirnaomics, Cholangiocarcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Varian Halcyon Treatment System Receives ANVISA Registration in Brazil
New advanced cancer treatment system from Varian now available to cancer centers in Brazil PALO ALTO, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Further expanding the global availability of its new device for cancer treatment, Va... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
New Assay Detects Adenovirus, Human Metapneumovirus and Rhinovirus Modular Panels, Including Influenza, RSV and Paraflu, Increase Efficiency and Flexibility for the Laboratory MARLBOROUGH, Mass., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network)... Diagnostics, FDA, Product Launch Hologic, Panther Fusion, Adenovirus, Metapneumovirus, Rhinovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
CIRM grant will support further development of Forty Seven Inc.'s CD47 antibody Hu5F9-G4 in an ongoing second trial for the treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome MENLO PARK, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketin... Biopharmaceuticals, Regenerative Medicine, Oncology Forty Seven, acute myeloid leukemia, Myelodysplastic Syndrome, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

Bioniz Therapeutics Appoints Graham Cooper to its Board of Directors
IRVINE, Calif., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively and simultaneousl... Biopharmaceuticals, Personnel Bioniz Therapeutics, cytokine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news

INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Late-breaking renal data from the integrated CANVAS Program presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting RARITAN, N.J. and NEW ORLEANS, Nov. 3, 2017 -- (Healthcare Sales & Marketing Network) -- Janssen Research & Deve... Biopharmaceuticals, Nephrology Janssen, INVOKANA, canagliflozin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
PHILADELPHIA, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- Lia Diagnostics, Inc. yesterday announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for over-the-counter use of the Lia Pregnancy Test, the first and only FDA-clear... Diagnostics, FDA Lia Diagnostics, Lia Pregnancy Test (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Appointment Further Bolsters Strong Board Which Includes Drs. Colón and Tweed-Kent BOSTON, Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- Cocoon Biotech, Inc., a biotechnology company with a broad drug delivery platform and an initial... Biopharmaceuticals, Drug Delivery, Ophthalmology, Personnel Cocoon Biotech, fibroin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news

AccuTec Blades(R) Announces Exclusive Australia-New Zealand DermaBlade(R) Agreement
Diplomat Blades designated as distributor of shave biopsy blade VERONA, Va., Dec. 5, 2017 -- (Healthcare Sales & Marketing Network) -- AccuTec Blades, Inc., a leader in specialty blade manufacturing, has entered into an agreement with Diplomat Blades t... Devices, Dermatology, Oncology, Distribution AccuTec Blades, DermaBlade, shave biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2017 Category: Pharmaceuticals Source Type: news